Skip to main content

Table 1 Metabolic syndrome definitions provided by various authorities

From: Visceral adiposity syndrome

Authority, yr

WHO 1998

EGIR 1999

ATP III (2001/4)

IDF 2005

Insulin resistance

IGT, IFG, T2D; insulin resistance + 2 below

Plasma insulin >75th percentile + 2 below

None; any 3 of the 5 below

None

BMI or body fat distribution

Men WHR >0.90

Women WHR >0.85 or BMI >30

WC ≥94 cm men or ≥80 cm women

WC >102 cm men or >88 cm women

Increased WC (pop. specific) + 2 below

Lipids

TG ≥150 mg/dL

HDL <35 men or <39 women

TG ≥ 150 mg/dL

HDL <39 in men or women

TG ≥150 mg/dL

HDL <40 men or <50 women

TG ≥150 mg/dL or Rx, HDL <40 men or <50 women or Rx

Glucose

IGT, IFG, T2D

IGT or IFG

≥110 mg/dL

≥100 mg/dL or diabetes

Blood pressure

≥140/≥90

≥140/≥90 or Htn Rx

≥130/≥85

≥130/≥85 or Htn Rx

Other

Urine alb >20 mg /min; ACR >30 mg/g

   
  1. WHO World Health Organization, EGIR European Group for the study of Insulin resistance, ATP adult treatment panel, IDF international diabetes federation, IGT impaired glucose tolerance, IFG impaired fasting glucose, T2D type 2 diabetes, BMI body mass index, WHR waist:hip ratio, Htn hypertension, Rx pharmacologic treatment, alb albumin, ACR albumin:creatinine ratio